Pharma-Bio Serv Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Cash & Equivalents	3.38	6.77	10.45	14.46	17.47
Short-Term Investments	7.48	5.98	4.53	-	-
Cash & Short-Term Investments	10.85	12.75	14.98	14.46	17.47
Cash Growth	-14.84%	-14.90%	3.56%	-17.21%	1.93%
Accounts Receivable	2.36	2.51	3.94	4.98	4.61
Receivables	2.36	2.51	3.94	4.98	4.61
Prepaid Expenses	0.17	0.44	0.48	0.5	0.74
Total Current Assets	13.39	15.7	19.4	19.94	22.82
Property, Plant & Equipment	0.15	0.37	0.39	0.58	0.75
Other Long-Term Assets	0.12	0.23	0.11	0.13	0.35
Total Assets	13.65	16.29	19.9	20.65	23.92
Accounts Payable	0.99	1.13	1.47	1.63	2.09
Current Portion of Leases	0.03	0.17	0.15	0.14	0.13
Current Income Taxes Payable	0.72	0.59	0.53	0.34	0.45
Total Current Liabilities	1.74	1.89	2.15	2.11	2.67
Long-Term Leases	-	0.03	0.19	0.35	0.49
Other Long-Term Liabilities	-	0.66	1.43	1.64	1.85
Total Liabilities	1.74	2.58	3.78	4.09	5.01
Common Stock	0	0	0	0	0
Additional Paid-In Capital	1.68	1.64	1.6	1.55	1.48
Retained Earnings	10.53	12.35	14.85	15.27	17.71
Treasury Stock	-0.58	-0.55	-0.54	-0.5	-0.42
Comprehensive Income & Other	0.28	0.26	0.21	0.24	0.14
Shareholders' Equity	11.91	13.72	16.13	16.56	18.91
Total Liabilities & Equity	13.65	16.29	19.9	20.65	23.92
Total Debt	0.03	0.19	0.35	0.49	0.62
Net Cash (Debt)	10.83	12.55	14.63	13.98	16.85
Net Cash Growth	-13.75%	-14.21%	4.69%	-17.07%	16.91%
Net Cash Per Share	0.47	0.55	0.64	0.61	0.73
Filing Date Shares Outstanding	22.9	22.96	22.96	22.95	22.97
Total Common Shares Outstanding	22.91	22.96	22.96	22.94	23
Working Capital	11.65	13.81	17.25	17.84	20.15
Book Value Per Share	0.52	0.60	0.70	0.72	0.82
Tangible Book Value	11.91	13.72	16.13	16.56	18.91
Tangible Book Value Per Share	0.52	0.60	0.70	0.72	0.82
Machinery	0.31	0.68	0.67	0.66	0.64

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.